天津医药 ›› 2020, Vol. 48 ›› Issue (4): 327-332.doi: 10.11958/20193666

• 指南与共识 • 上一篇    下一篇

重症肌无力外科治疗京津冀专家共识

京津冀重症肌无力联盟   

  1. 天津医科大学总医院(邮编 300052
  • 收稿日期:2019-12-05 修回日期:2019-12-31 出版日期:2020-04-15 发布日期:2020-06-23
  • 基金资助:
    天津市科技计划项目科技重大专项与工程(16ZXMJSY00030);天津市自然科学基金京津冀专项项目(19JCZDJC64400Z))

Consensus on surgical treatment of myasthenia gravis of the Jing-Jin-Ji experts #br#

Myasthenia Gravis Union of Jing-Jin-Ji   

  1. Tianjin General Hospital
  • Received:2019-12-05 Revised:2019-12-31 Published:2020-04-15 Online:2020-06-23

摘要: 重症肌无力(MG)是乙酰胆碱受体抗体介导的、细胞免疫依赖和补体参与的神经肌肉接头(NMJ)处传递障
碍的自身免疫性疾病。
MG与胸腺病变密切相关,故除内科治疗外,胸腺切除术是治疗 MG的一种重要方式。本文通
过查阅国内外最新文献,汇集京津冀十余位本领域专家经验,针对
MG的抗体分型、术前检查、手术指征、手术方式、
术后治疗及随访写成专家共识,希望能指导
MG的外科治疗。

关键词: 重症肌无力, 胸腺, 外科治疗

Abstract: Myasthenia gravis (MG) is an autoimmune disease with dystransmission at the neuromuscular junction
(NMJ), which is mediated by acetylcholine receptor antibody, dependent on cellular immunity and participated by
complement. MG is closely related to thymic diseases, so in addition to the medical treatment, thymectomy is an important
way to treat MG. Based on the latest literature at home and abroad, and the experience of more than ten experts in Beijing, Tianjin and Hebei, this paper has written an expert consensus on antibody typing, preoperative examination, surgical indications, surgical methods, postoperative treatment and follow-up of MG, hoping to guide the surgical treatment of MG.

Key words: myasthenia gravis, thymus, surgical treatment

中图分类号: